Company intelligence / Profile preview
Wuhan Huajiyuan Biotechnology Development
- Ownership
- Private
- Development stage
- Other
Overview
Wuhan Huajiyuan Biotechnology Development is a biotechnology company based in the Optics Valley of Wuhan, China, specializing in cellular medicine and regenerative technologies. The company focuses on the research, development, and technical service of stem cells and immune cells, including their extraction, expansion, and storage. Huajiyuan's operations include the development of biological reagents and the provision of technical support for clinical research in the life sciences. By leveraging its expertise in cell biology, the firm seeks to advance treatments for chronic diseases and support the growing field of personalized medicine.
- Therapeutic areas
- Other
- Modalities
- Cell therapyStem cell therapy
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Wuhan Huajiyuan Biotechnology Development.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wuhan Huajiyuan Biotechnology Development.